1. A case of psoriasis pustolosa palmaris induced by cetuximab. (18th March 2016) Authors: Marinello, Elena; Pastorelli, Davide; Alaibac, Mauro Journal: BMJ case reports Issue: Volume 2016 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating endothelial cells and risk of progression in patients with hepatocellular cancer receiving sorafenib. (April 2017) Authors: Giovanis, Petros; Pianezze, Graziano; Vincenzi, Valter; Manuppelli, Carla; Boaretto, Massimo; Pastorelli, Davide Journal: Hepatic oncology Issue: Volume 4:Number 2(2017) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17–25]. (September 2018) Authors: Chau, Ian; Peck-Radosavljevic, Markus; Borg, Christophe; Malfertheiner, Peter; Seitz, Jean Francois; Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Kudo, Masatoshi; Poon, Ronnie; Pastorelli, Davide; Blanc, Jean-Frederic; Chung, Hyun Cheol; Baron, Ari D.; Okusaka, Takuji; Bowman, L.; Cui, Zhanglin... Journal: European journal of cancer Issue: Volume 100(2018) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study. (April 2021) Authors: Guarneri, Valentina; Bassan, Franco; Zagonel, Vittorina; Milella, Michele; Zaninelli, Marta; Cattelan, Anna Maria; Vianello, Andrea; Gori, Stefania; Aprile, Giuseppe; Azzarello, Giuseppe; Chiari, Rita; Favaretto, Adolfo; Oliani, Cristina; Scola, Annamaria; Pastorelli, Davide; Mandarà, Marta; Zust... Journal: European journal of cancer Issue: Volume 147(2021) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impressive response to denosumab in a patient with bone metastatic adenocarcinoma of the stomach after 2 years of zoledronic acid. Issue 2 (February 2015) Authors: Cappetta, Alessandro; Spano, Laura; Evangelista, Laura; Zovato, Stefania; Opocher, Giuseppe; Pastorelli, Davide Journal: Anti-cancer drugs Issue: Volume 26:Issue 2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impressive response to denosumab in a patient with bone metastatic adenocarcinoma of the stomach after 2 years of zoledronic acid. Issue 2 (February 2015) Authors: Cappetta, Alessandro; Spano, Laura; Evangelista, Laura; Zovato, Stefania; Opocher, Giuseppe; Pastorelli, Davide Journal: Anti-cancer drugs Issue: Volume 26:Issue 2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mesenteric-Portal Vein Resection during Pancreatectomy for Pancreatic Cancer. (1st November 2015) Authors: Beltrame, Valentina; Gruppo, Mario; Pedrazzoli, Sergio; Merigliano, Stefano; Pastorelli, Davide; Sperti, Cosimo Other Names: Besselink Marc Academic Editor. Journal: Gastroenterology research and practice Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial. (June 2018) Authors: Pastorelli, Davide; Fabricio, Aline S.C.; Giovanis, Petros; D'Ippolito, Simona; Fiduccia, Pasquale; Soldà, Caterina; Buda, Andrea; Sperti, Cosimo; Bardini, Romeo; Da Dalt, Gianfranco; Rainato, Giulia; Gion, Massimo; Ursini, Fulvio Journal: Pharmacological research Issue: Volume 132(2018) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study. (August 2017) Authors: Chau, Ian; Peck-Radosavljevic, Markus; Borg, Christophe; Malfertheiner, Peter; Seitz, Jean Francois; Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Kudo, Masatoshi; Poon, Ronnie; Pastorelli, Davide; Blanc, Jean-Frederic; Chung, Hyun Cheol; Baron, Ari D.; Okusaka, Takuji; Bowman, L.; Cui, Zhanglin... Journal: European journal of cancer Issue: Volume 81(2017) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial. Issue 7 (July 2015) Authors: Zhu, Andrew X; Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Poon, Ronnie; Pastorelli, Davide; Blanc, Jean-Frederic; Chung, Hyun Cheol; Baron, Ari D; Pfiffer, Tulio Eduardo Flesch; Okusaka, Takuji; Kubackova, Katerina; Trojan, Jorg; Sastre, Javier; Chau, Ian; Chang, Shao-Chun; Abada, Paolo B; Ya... Journal: Lancet oncology Issue: Volume 16:Issue 7(2015:Jul.) Page Start: 859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗